3 Point Analysis | Ranitidine Ban Impact
Moneycontrol
2019-09-30
Views 24
Recent news flows regarding a potential ban on drug used for acid reflux - Raniti-dine had a knee-jerk impact on some of the Indian pharma and API companies.
Sakshi Batra does a 3 point analysis of why this drug is under the lens and what could this mean for pharma and API companies
Sakshi Batra does a 3 point analysis of why this drug is under the lens and what could this mean for pharma and API companies
Report form
RELATED VIDEOS
